Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 2, 2015, Pages 243-254

  Henry, C ^a   Quadir, A ^a   Hawkins, N J ^b   Jary, E ^a   Llamosas, E ^a   Kumar, D ^a   Daniels, B ^b   Ward, R L ^a   Ford, C E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Breast cancer; Metastasis; ROR2; Wnt signalling; Catenin

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE DERIVATIVE; BETA CATENIN; FRIZZLED PROTEIN; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 2; UNCLASSIFIED DRUG; MESSENGER RNA; ROR2 PROTEIN, HUMAN; WNT PROTEIN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRIPLE NEGATIVE BREAST CANCER; WNT SIGNALING PATHWAY; APOPTOSIS; BREAST; CANCER STAGING; CELL CULTURE; CELL MOTION; COMPARATIVE STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR INVASION; WESTERN BLOTTING;

APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; BREAST; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; WNT PROTEINS;

EID: 84921022827     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1824-y     Document Type: Article

References (18)

1. Albring KF et al (2013) Berberine acts as a natural inhibitor of Wnt/beta-catenin signaling—identification of more active 13-arylalkyl derivatives. BioFactors 39:652–662. doi:10.1002/biof.1133
2. Arnaout-Alkarain A, Kahn HJ, Narod SA, Sun PA, Marks AN (2007) Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 20:183–191
3. Curtis C et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346–352 10.1038/nature10983
4. Ford CE, Ma Q, Si S, Quadir A, Ward RL (2013) The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int J Cancer 133:779–787
5. Geback T, Schulz MM, Koumoutsakos P, Detmar M (2009) TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265–274. doi:10.2144/000113083
6. Ishitani T et al (2003) The TAK1–NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2 +) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131–139
7. Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG (2010) Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 63:721–727. doi:10.1016/j.jclinepi.2009.12.008
8. Lee AH, Pinder SE, Macmillan RD, Mitchell M, Ellis IO, Elston CW, Blamey RW (2006) Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42:357–362
9. Loh YN, Hedditch EL, Baker LA, Jary E, Ward RL, Ford CE (2013) The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer 13:174
10. Mohammed RA, Ellis IO, Mahmmod AM, Hawkes EC, Green AR, Rakha EA, Martin SG (2011) Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance. Mod Pathol 24:774–785
11. Pierpaoli E, Arcamone AG, Buzzetti F, Lombardi P, Salvatore C, Provinciali M (2013) Antitumor effect of novel berberine derivatives in breast cancer cells. BioFactors 39:672–679. doi:10.1002/biof.1131
12. Rasmussen NR et al (2013) Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer. J Biol Chem 288:26301–26310
13. Saneyoshi T, Kume S, Amasaki Y, Mikoshiba K (2002) The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature 417:295–299. doi:10.1038/417295a
14. Sorlie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874. doi:10.1073/pnas.191367098
15. Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI (2012) Berberine: new perspectives for old remedies. Biochem Pharmacol 84:1260–1267. doi:10.1016/j.bcp.2012.07.018
16. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899–908
17. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
18. Webster LR et al (2008) Poor-prognosis estrogen receptor–positive breast cancer identified by histopathologic subclassification. Clin Cancer Res 14:6625–6633